Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
AstraZeneca
CG Oncology, Inc.
Eli Lilly and Company
Astellas Pharma Inc
Eli Lilly and Company
Eli Lilly and Company
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc.